The Stereoselective O-methylation of Isoprenaline in the Isolated Rabbit Thoracic Aorta
Overview
Authors
Affiliations
This investigation examined the stereoselective nature of the steroid-sensitive extraneuronal O-methylation process for the isomers of isoprenaline in the rabbit aorta. The rate of O-methylation of (-)- and (+)-isoprenaline was linear with substrate concentration in the range 0.24 to 4.7 mumol X 1(-1). There was marked preference for the O-methylation of (-)-isoprenaline rather than (+)-isoprenaline at low (less than 0.94 mumol X 1(-1) substrate concentrations. In contrast, at concentrations equal to or greater than 9.4 mumol X 1(-1) the rates of O-methylation of (-)- and (+)-isoprenaline were similar. Phenoxybenzamine (30 mumol X 1(-1) inhibited but did not abolish the O-methylation of both (-)- and (+)-isoprenaline when the isomers were present in a concentration range of 0.24 mumol X 1(-1) to 9.4 mumol X 1(-1). Phenoxybenzamine did not significantly influence the O-methylation of either (-)- or (+)-isoprenaline when the isomers were present at a concentration of 24 mumol X 1(-1). Deoxycorticosterone acetate (DOCA) produced an equipotent and marked inhibition of the O-methylation of both (-)- and (+)-isoprenaline at a low (0.24 mumol X 1(-1) substrate concentration. When higher substrate concentrations were used, there was a significantly greater resistance to the inhibition of O-methylation of (-)-isoprenaline than was the case for (+)-isoprenaline. At a concentration of 9.4 mumol X 1(-1), the steroid failed to inhibit the O-methylation of (-)-isoprenaline but was effective in inhibiting the O-methylation of (+)-isoprenaline.(ABSTRACT TRUNCATED AT 250 WORDS)
Rudolf Buchheim lecture. The metabolizing systems involved in the inactivation of catecholamines.
Trendelenburg U Naunyn Schmiedebergs Arch Pharmacol. 1986; 332(3):201-7.
PMID: 3713866 DOI: 10.1007/BF00504854.
REID J, Stitzel R, Head R Naunyn Schmiedebergs Arch Pharmacol. 1986; 334(1):17-28.
PMID: 3024022 DOI: 10.1007/BF00498735.
Bryan-Lluka L, Vuocolo H Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(4):399-404.
PMID: 1359431 DOI: 10.1007/BF00171081.